Back to Search Start Over

Soft Tissue Tumor with PAK2::RAF1 Kinase Fusion: An Emerging Sarcoma Entity.

Authors :
Haglund C
Behrendtz M
Hesla A
Haglund de Flon F
Source :
Case reports in oncology [Case Rep Oncol] 2024 Aug 30; Vol. 17 (1), pp. 960-965. Date of Electronic Publication: 2024 Aug 30 (Print Publication: 2024).
Publication Year :
2024

Abstract

Introduction: Here, we report the first case of a soft tissue tumor with a PAK2::RAF1 fusion.<br />Case Presentation: The patient was an 11-year-old female presenting with a 5 cm intramuscular mass in the lower leg. Microscopic examination revealed a mitotically active spindle cell lesion with monomorphic and moderately atypical cells growing in a patternless pattern with the presence of stromal and perivascular keloidal collagen with focal immunoreactivity for smooth muscle actin and S100; negative stains included cytokeratins, CD34, and caldesmon. Whole genome and RNA sequencing detected a chromosome 3 inversion and a resultant PAK2::RAF1 fusion as well as a CDKN2A homozygous deletion. The patient was treated with neoadjuvant chemoradiotherapy with only minimal response and the tumor was excised surgically. There was no evidence of disease progression at 4 months.<br />Conclusion: This is the first case of a soft tissue tumor harboring a PAK2::RAF1 fusion with histological features in keeping with previous cases of RAF1 and other kinase fusion soft tissue tumors.<br />Competing Interests: The authors have no conflicts of interest to declare.<br /> (© 2024 The Author(s). Published by S. Karger AG, Basel.)

Details

Language :
English
ISSN :
1662-6575
Volume :
17
Issue :
1
Database :
MEDLINE
Journal :
Case reports in oncology
Publication Type :
Academic Journal
Accession number :
39474563
Full Text :
https://doi.org/10.1159/000540581